DM1 CTG expansions affect insulin receptor isoforms expression in various tissues of transgenic mice

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1772, Issue 11-12, 2007, Pages 1183-1191

  Guiraud Dogan, Céline ^a   Huguet, Aline ^a   Gomes Pereira, Mário ^a   Brisson, Edith ^a   Bassez, Guillaume ^b   Junien, Claudine ^a   Gourdon, Geneviève ^a  

^a INSERM   (France)

^b HENRI MONDOR HOSPITAL   (France)

Author keywords

Insulin receptor; Myotonic dystrophy; Splicing; Transgenic mice; Trinucleotide repeat

Indexed keywords

INSULIN RECEPTOR; RECEPTOR SUBUNIT;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; GENETIC REGULATION; GLUCOSE INTOLERANCE; GLUCOSE METABOLISM; HYPERGLYCEMIA; INSULIN RESPONSE; LIVER; MOUSE; MUTAGENESIS; MYOTONIC DYSTROPHY; NONHUMAN; PANCREAS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA SPLICING; SKELETAL MUSCLE; TRANSGENIC MOUSE;

AGING; ALTERNATIVE SPLICING; ANIMALS; GENE EXPRESSION PROFILING; GLUCOSE; GLUCOSE TOLERANCE TEST; HUMANS; HYPOTHALAMUS; INSULIN; MICE; MICE, TRANSGENIC; MUTANT PROTEINS; MYOTONIC DYSTROPHY; ORGAN SPECIFICITY; PANCREAS; PROTEIN ISOFORMS; PROTEIN-SERINE-THREONINE KINASES; RECEPTOR, INSULIN; RNA, MESSENGER; TRANSGENES; TRINUCLEOTIDE REPEAT EXPANSION;

MUS; MUS MUSCULUS;

EID: 37049035297     PISSN: 09254439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbadis.2007.08.004     Document Type: Article

References (40)

1. Harper P.S. Myotonic Dystrophy. 3rd edition (2001), London, Philadelphia
2. Caughey J.E. S.G. Endocrine aspects of dystrophia myotonica. Brain 85 (1962) 711-732
3. Moxley R.T., Corbett A.J., Minaker K.L., and Rowe J.W. Whole body insulin resistance in myotonic dystrophy. Ann. Neurol. 15 (1984) 157-162
4. Kunze D., and Olthoff D. Lipid content of human skeletal muscle in primary and secondary myopathies. Clin. Chim. Acta 29 (1970) 455-462
5. Fernandez-Real J.M., Molina A., Broch M., Ricart W., Gutierrez C., Casamitjana R., Vendrell J., Soler J., and Gomez-Saez J.M. Tumor necrosis factor system activity is associated with insulin resistance and dyslipidemia in myotonic dystrophy. Diabetes 48 (1999) 1108-1112
6. Wakamatsu H., Nakamura H., Ito K., Anazawa W., Okajima S., Shigeno K., and Goto Y. Concentration and fatty acid composition of serum lipids in myotonia dystrophica. With special reference to pathogenesis. Horm. Metab. Res. 4 (1972) 458-462
7. Aslanidis C., Jansen G., Amemiya C., Shutler G., Mahadevan M., Tsilfidis C., Chen C., Alleman J., Wormskamp N.G., Vooijs M., Buxton J., Johnson K., Smeets H.J.M., Lennon G.G., Carrano A.V., Korneluk R.G., Wieringa B., and de Jond P.J. Cloning of the essential myotonic dystrophy region and mapping of the putative defect. Nature 355 (1992) 548-551
8. Brook J.D., McCurrach M.E., Harley H.G., Buckler H.J., Church D., Aburatani H., Hunter K., Stanton V.P., Thirion J.P., Hudson T., Sohn R., Zemelman B., Snell R.G., Rundle S.A., Crow S., Davies J., Shelbourne P., Buxton J., Jones C., Juvonen V., Johnson K., Harper P.S., Shaw D.J., and Housman D.E. Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3′ end of a transcript encoding a protein kinase family member. Cell 68 (1992) 799-808
9. Fu Y.H., Pizzuti A., Fenwick Jr. R.G., King J., Rajnarayan S., Dunne P.W., Dubel J., Nasser G.A., Ashizawa T., de Jong P., et al. An unstable triplet repeat in a gene related to myotonic muscular dystrophy. Science 255 (1992) 1256-1258
10. Mahadevan M., Tsilfidis C., Sabourin L., Shutler G., Amemiya C., Jansen G., Neville C., Narang M., Barcelo J., O'Hoy K., et al. Myotonic dystrophy mutation: an unstable CTG repeat in the 3′ untranslated region of the gene. Science 255 (1992) 1253-1255
11. Zerylnick C., Torroni A., Sherman S.L., and Warren S.T. Normal variation at the myotonic dystrophy locus in global human populations. Am. J. Hum. Genet. 56 (1995) 123-130
12. Machuca-Tzili L., Brook D., and Hilton-Jones D. Clinical and molecular aspects of the myotonic dystrophies: a review. Muscle Nerve 32 (2005) 1-18
13. Taneja K.L., Mccurrach M., Schalling M., Housman D., and Singer R.H. Foci of trinucleotide repeat transcripts in nuclei of myotonic dystrophy cells and tissues. J. Cell Biol. 128 (1995) 995-1002
14. Davis B.M., McCurrach M.E., Taneja K.L., Singer R.H., and Housman D.E. Expansion of a CUG trinucleotide repeat in the 3′ untranslated region of myotonic dystrophy protein kinase transcripts results in nuclear retention of transcripts. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 7388-7393
15. Otten A.D., and Tapscott S.J. Triplet repeat expansion in myotonic dystrophy alters the adjacent chromatin structure. Proc. Natl. Acad. Sci. U. S. A. 92 (1995) 5465-5469
16. Cho D.H., Thienes C.P., Mahoney S.E., Analau E., Filippova G.N., and Tapscott S.J. Antisense transcription and heterochromatin at the DM1 CTG repeats are constrained by CTCF. Mol. Cell 20 (2005) 483-489
17. Ranum L.P., and Cooper T.A. RNA-Mediated Neuromuscular Disorders. Annu. Rev. Neurosci. 29 (2006) 259-277
18. Ebralidze A., Wang Y., Petkova V., Ebralidse K., and Junghans R.P. RNA leaching of transcription factors disrupts transcription in myotonic dystrophy. Science 303 (2004) 383-387
19. Mankodi A., Logigian E., Callahan L., McClain C., White R., Henderson D., Krym M., and Thornton C.A. Myotonic dystrophy in transgenic mice expressing an expanded CUG repeat. Science 289 (2000) 1769-1773
20. Seznec H., Agbulut O., Sergeant N., Savouret C., Ghestem A., Tabti N., Willer J.C., Ourth L., Duros C., Brisson E., Fouquet C., Butler-Browne G., Delacourte A., Junien C., and Gourdon G. Mice transgenic for the human myotonic dystrophy region with expanded CTG repeats display muscular and brain abnormalities. Hum. Mol. Genet. 10 (2001) 2717-2726
21. Moxley III R.T., Kingston W.J., Minaker K.L., Corbett A.J., and Rowe J.W. Insulin resistance and regulation of serum amino acid levels in myotonic dystrophy. Clin. Sci. (Lond.) 71 (1986) 429-436
22. Perseghin G., Caumo A., Arcelloni C., Benedini S., Lanzi R., Pagliato E., Sereni L.P., Testolin G., Battezzati A., Comi G., Comola M., and Luzi L. Contribution of abnormal insulin secretion and insulin resistance to the pathogenesis of type 2 diabetes in myotonic dystrophy. Diabetes Care 26 (2003) 2112-2118
23. Perseghin G., Comola M., Scifo P., Benedini S., De Cobelli F., Lanzi R., Costantino F., Lattuada G., Battezzati A., Del Maschio A., and Luzi L. Postabsorptive and insulin-stimulated energy and protein metabolism in patients with myotonic dystrophy type 1. Am. J. Clin. Nutr. 80 (2004) 357-364
24. Morrone A., Pegoraro E., Angellini C., Zammarchi E., Marconi G., and Hoffman E.P. RNA metabolism in myotonic dystrophy. J. Clin. Invest. 99 (1997) 1691-1698
25. Savkur R.S., Philips A.V., and Cooper T.A. Aberrant regulation of insulin receptor alternative splicing is associated with insulin resistance in myotonic dystrophy. Nat. Genet. 29 (2001) 40-47
26. Mosthaf L., Grako K., Dull T.J., Coussens L., Ullrich A., and McClain D.A. Functionally distinct insulin receptors generated by tissue-specific alternative splicing. EMBO J. 9 (1990) 2409-2413
27. Yamaguchi Y., Flier J.S., Yokota A., Benecke H., Backer J.M., and Moller D.E. Functional properties of two naturally occurring isoforms of the human insulin receptor in Chinese hamster ovary cells. Endocrinology 129 (1991) 2058-2066
28. Vogt B., Carrascosa J.M., Ermel B., Ullrich A., and Haring H.U. The two isotypes of the human insulin receptor (HIR-A and HIR-B) follow different internalization kinetics. Acta Haematol. 177 (1991) 1013-1018
29. Kellerer M., Lammers R., Ermel B., Tippmer S., Vogt B., Obermaier-Kusser B., Ullrich A., and Haring H.U. Distinct alpha-subunit structures of human insulin receptor A and B variants determine differences in tyrosine kinase activities. Biochemistry 31 (1992) 4588-4596
30. Berggren P.O., and Leibiger I.B. Novel aspects on signal-transduction in the pancreatic beta-cell. Nutr. Metab. Cardiovasc. Dis. 1 (2006) S7-S10
31. Fiorelli M., Duboc D., Mazoyer B.M., Blin J., Eymard B., Fardeau M., and Samson Y. Decreased cerebral glucose utilization in myotonic dystrophy. Neurology 42 (1992) 91-94
32. Mielke R., Herholz K., Fink G., Ritter D., and Heiss W.D. Positron emission tomography in myotonic dystrophy. Psychiatry Res. 50 (1993) 93-99
33. Plum L., Schubert M., and Bruning J.C. The role of insulin receptor signaling in the brain. Trends Endocrinol. Metab. 16 (2005) 59-65
34. Bruning J.C., Gautam D., Burks D.J., Gillette J., Schubert M., Orban P.C., Klein R., Krone W., Muller-Wiel D., and Kahn C.R. Role of brain insulin receptor in control of body weight and reproduction. Science 289 (2000) 2122-2125
35. Morrone A., Pegoraro E., Angelini C., Zammarchi E., Marconi G., and Hoffman E.P. RNA metabolism in myotonic dystrophy: patient muscle shows decreased insulin receptor RNA and protein consistent with abnormal insulin resistance. J. Clin. Invest. 99 (1997) 1691-1698
36. Dansithong W., Paul S., Comai L., and Reddy S. MBNL1 is the primary determinant of focus formation and aberrant insulin receptor splicing in DM1. J. Biol. Chem. 280 (2005) 5773-5780
37. Savkur R.S., Philips A.V., Cooper T.A., Dalton J.C., Moseley M.L., Ranum L.P., and Day J.W. Insulin receptor splicing alteration in myotonic dystrophy type 2. Am. J. Hum. Genet. 74 (2004) 1309-1313
38. Paul S., Dansithong W., Kim D., Rossi J., Webster N.J., Comai L., and Reddy S. Interaction of muscleblind, CUG-BP1 and hnRNP H proteins in DM1-associated aberrant IR splicing. EMBO J. 25 (2006) 4271-4283
39. Leroy O., Dhaenens C.M., Schraen-Maschke S., Belarbi K., Delacourte A., Andreadis A., Sablonniere B., Buee L., Sergeant N., and Caillet-Boudin M.L. ETR-3 represses Tau exons 2/3 inclusion, a splicing event abnormally enhanced in myotonic dystrophy type I. J. Neurosci. Res. 84 (2006) 852-859
40. Ho T.H., Charlet B.N., Poulos M.G., Singh G., Swanson M.S., and Cooper T.A. Muscleblind proteins regulate alternative splicing. EMBO J. 23 (2004) 3103-3112